Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent ...

Dr. Keith Stewart of The Princess Margaret offers an inside look at the cutting-edge clinical trials and treatments that ...

Effects of zongertinib on physical functioning and symptoms for patients with pretreated HER2-mutant advanced non-small cell lung cancer (NSCLC): Results from the Beamion LUNG-1 trial. This is an ASCO ...

People in Ontario will have fast-tracked access to some new cancer drugs, Sylvia Jones, the province's deputy premier and minister of health, has announced.

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...

Ontario says it will speed up the lengthy approval process for select cancer drugs by up to one year as part of a new pilot ...

We trained and tested ML systems that predict a deterioration in nine patient-reported symptoms within 30 days after treatments for aerodigestive cancers, using internal electronic health record (EHR) ...

A new report from The Lancet medical journal suggests the trend is expected to play out in Canada, too — and health-care systems need to start preparing now.

A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...